⌘K

Login Start Free

Home/Filings/4/A/0000897069-25-000294

4/A//SEC Filing

Young David 4/A

Accession 0000897069-25-000294

CIK 0001533743other

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 5:57 PM ET

Size

9.8 KB

Accession

0000897069-25-000294

Insider Transaction Report

Form 4/AAmended

Period: 2025-01-27

Processa Pharmaceuticals, Inc.PCSA

DirectorPres. Research & Development

Transactions

Award
Warrants
2025-01-29+124,500→ 124,500 total
Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (124,500 underlying)
Award
Warrants
2025-01-29+62,250→ 62,250 total
Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (62,250 underlying)

Holdings

Common Stock
(indirect: By Family Entities)
10,786
Common Stock
205,405
Common Stock
(indirect: By Trust)
30,985
Common Stock
(indirect: By LLC)
18,544

Documents

1 file

4
form4.xml

Issuer

Processa Pharmaceuticals, Inc.

CIK 0001533743

Entity typeother

Related Parties

1

filerCIK 0001378166

Filing Metadata

Form type: 4/A
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 5:57 PM ET
Size: 9.8 KB

View on SEC.gov